Degenerative Diseases of the CNS Flashcards

1
Q

What are the common features of neurodegenerative diseases?

A

Aetiology is largely unknown, usually later onset, gradual progression, neuronal loss and structural imagining is often normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is dementia?

A

Progressive impairment of multiple domains of cognitive function in alert patient
Leads to loss of acquired skills and interference of occupational and social role

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the incidence and prevalence of dementia?

A

Incidence is 200 pre 100000
Prevalence is 1500 pre 100000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is dementia important?

A

High incidence and prevalence
Devastating impact on patient and family
Is expensive for the NHS - esp. care homes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the causes of later onset dementia?

A

Alzheimer’s, vascular, Lewy body and others
Often mixed pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the causes of young onset dementia?

A

Alzheimer’s, vascular, frontotemporal and other - alcohol, Huntington’s, HIV, CJD and MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are treatable causes of dementia?

A

Vitamin B12 deficiency
Thyroid disease
HIV and syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are mimics of dementia?

A

Hydrocephalus, tumour and depression - pseudodementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is dementia diagnosed?

A

History - type of deficit, progression, risk factors, FH
Exam - cognitive function, neurological and vascular
Investigations - Bloods, CT/MRI, CSF, EEG, functional imaging and genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is cognitive function examined?

A

Screening testes - Mini-mental MMSE and Montreal MOCA
Neuropsychological assessment
Examine memory, attention, language, visuospatial, behaviour, emotion…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some clues to diagnosis of dementia?

A

Type of cognitive deficit, speed of progression - rapid (CJD) and stepwise (vascular)
Other neurological signs - abnormal movements (Huntington’s), parkinsonism (Lewy body) and myoclonus (CJD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Alzheimer’s disease

A

Commonest neuro-divergent condition - mean onset is 70 years old
Tempero-parietal dementia - early memory disturbance, language + visuospatial problems and personality is persevered until later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathology of Alzheimer’s disease?

A

B amyloid plaques and neurofibrillary tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the risks of Alzheimer’s disease?

A

Genetic - APOE, APP, PSEN1+2
Environmental
Increase risk - smoking, obesity, diabetes and hypertension
Decrease risk - cognitive reserve, exercise and diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe frontotemporal dementia

A

Tau pathology
Early change in personality/ behaviour
Early dysphasia and often change in eating habits
Memory and visuospatial is relatively persevered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe dementia with Lewy bodies

A

Early visuospatial and executive dysfunction
Prominent fluctuation
Parkinsonism and visual hallucinations common

17
Q

Describe vascular dementia

A

Mixed picture (parts of brain affected)
Stepwise decline

18
Q

What is non pharmacological treatment of dementia?

A

Occupational therapy, social work, support, and voluntary organisations

19
Q

What symptoms can be treated in dementia?

A

Insomnia, behaviour (care with antipsychotics) and depression

20
Q

What is specific treatment for Alzheimer’s disease (also Lewy body)?

A

Cholinesterase inhibitors - donepezil, rivastigmine, galantamine. Small symptomatic improvement of cognition
NDMA antagonist - memantine

21
Q

What is the frontotemporal specific treatment?

A

None

22
Q

What is the specific treatment for vascular dementia?

A

No robust evidence for decreased vascular risk factors

23
Q

Describe parkinsonism

A

Clinical syndrome with more than 2 of - bradykinesia, rigidity, tremor, and postural instability

24
Q

Describe the pathology of parkinsonism

A

Predominantly dopamine loss
Lewy bodies

25
Q

What are causes of Parkinson’s disease?

A

Idiopathic - dementia with Lewy bodies
Drug induced (dopamine antagonists)
Vascular parkinsonism
Parkinson’s plus syndromes - multiple system atrophy and progressive supranuclear palsy

26
Q

What are the risk factors of PD?

A

Genetic - LRRK2, Parkin, GBA
Environmental - pesticides, smoking and caffeine

27
Q

How is Parkinson’s disease clinically diagnosed?

A

Bradykinesia + more than 1 - rigidity, tremor, instability
Slowly progressive
Supported by asymmetric rest tremor and good response to dopamine replacement treatment

28
Q

What are some cardinal signs of parkinsonism?

A

Tremor - unilateral and at rest
Bradykinesia - progressive decrement and asymmetry
Postural instability

29
Q

What are some non-motor symptoms of PD?

A

Anosmia, REM sleep behaviour disorder, autonomic (constipation, urinary), neuropsychiatric (hallucinations, cognitive) and depression

30
Q

How can PD look on functional imaging?

A

Dopamine transporter SPECT
Dopamine will be strongly in basal ganglia
Decreases in PD

31
Q

What is the early treatment of PD?

A

Levodopa
With carbidopa or benserazide
Also with COMT inhibitor - entacapone, tolcapone and opicapone
Dopamine agonists
MOAB inhibitor

32
Q

What are later complications of PD?

A

Drug induced - motor fluctuations as levodopa wears off, dyskinesis and psychiatric
Also falls, balance, dementia, speech, swallow and gait freezing

33
Q

What is the late treatment for PD?

A

Prolong levodopa half life - MAOB and COMT inhibitors, and slow release levodopa
Add oral dopamine agonist
Continuous infusion
Functional neurosurgery
Allied health professionals